Recent breakthroughs in the field of obesity treatment have presented a new candidate known as ALLUVI Retatrutide. This substance is a {highlyeffective GLP-1 receptor agonist, engineered to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown significant results in clinical trials, demonstrating significant reductions in body